Illinois Municipal Retirement Fund cut its stake in shares of Teradyne, Inc. (NASDAQ:TER - Free Report) by 8.1% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 106,090 shares of the company's stock after selling 9,330 shares during the period. Illinois Municipal Retirement Fund owned 0.07% of Teradyne worth $8,763,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Roberts Glore & Co. Inc. IL increased its stake in Teradyne by 2.2% during the 4th quarter. Roberts Glore & Co. Inc. IL now owns 4,103 shares of the company's stock worth $517,000 after buying an additional 90 shares during the period. Covestor Ltd lifted its stake in shares of Teradyne by 12.3% in the fourth quarter. Covestor Ltd now owns 901 shares of the company's stock worth $113,000 after acquiring an additional 99 shares in the last quarter. Snowden Capital Advisors LLC boosted its holdings in Teradyne by 2.8% in the fourth quarter. Snowden Capital Advisors LLC now owns 3,748 shares of the company's stock valued at $472,000 after purchasing an additional 103 shares during the last quarter. CIBC Private Wealth Group LLC grew its stake in Teradyne by 4.0% during the 4th quarter. CIBC Private Wealth Group LLC now owns 3,127 shares of the company's stock valued at $429,000 after purchasing an additional 119 shares in the last quarter. Finally, Citizens Financial Group Inc. RI grew its stake in Teradyne by 5.8% during the 4th quarter. Citizens Financial Group Inc. RI now owns 2,244 shares of the company's stock valued at $283,000 after purchasing an additional 124 shares in the last quarter. Institutional investors and hedge funds own 99.77% of the company's stock.
Teradyne Stock Performance
Shares of NASDAQ TER traded up $2.15 during trading on Tuesday, hitting $92.07. The company had a trading volume of 1,552,632 shares, compared to its average volume of 2,693,402. The company has a market cap of $14.77 billion, a P/E ratio of 26.06, a PEG ratio of 3.95 and a beta of 1.69. The business's 50-day moving average is $81.60 and its 200 day moving average is $98.56. Teradyne, Inc. has a 52 week low of $65.77 and a 52 week high of $163.21.
Teradyne (NASDAQ:TER - Get Free Report) last released its earnings results on Monday, April 28th. The company reported $0.75 earnings per share for the quarter, topping the consensus estimate of $0.61 by $0.14. Teradyne had a net margin of 19.86% and a return on equity of 20.06%. The business had revenue of $685.70 million for the quarter, compared to the consensus estimate of $680.54 million. During the same period last year, the firm posted $0.51 earnings per share. The firm's quarterly revenue was up 14.3% compared to the same quarter last year. On average, research analysts expect that Teradyne, Inc. will post 3.88 EPS for the current year.
Teradyne declared that its Board of Directors has approved a share buyback plan on Monday, April 28th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the company to repurchase up to 8.1% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's board believes its stock is undervalued.
Teradyne Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Thursday, May 22nd were given a $0.12 dividend. The ex-dividend date of this dividend was Thursday, May 22nd. This represents a $0.48 annualized dividend and a dividend yield of 0.52%. Teradyne's dividend payout ratio (DPR) is presently 13.56%.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on the stock. Cantor Fitzgerald set a $105.00 target price on shares of Teradyne and gave the stock an "overweight" rating in a research report on Tuesday, June 24th. Susquehanna cut their price objective on Teradyne from $155.00 to $133.00 and set a "positive" rating on the stock in a research note on Wednesday, April 30th. Robert W. Baird reduced their target price on Teradyne from $140.00 to $110.00 and set an "outperform" rating on the stock in a report on Thursday, March 13th. JPMorgan Chase & Co. lowered their price target on Teradyne from $120.00 to $92.00 and set an "overweight" rating for the company in a report on Thursday, April 17th. Finally, TD Cowen reduced their price objective on Teradyne from $135.00 to $110.00 and set a "buy" rating on the stock in a research note on Wednesday, March 12th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Teradyne has a consensus rating of "Moderate Buy" and a consensus target price of $114.33.
Get Our Latest Stock Report on TER
Teradyne Company Profile
(
Free Report)
Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.
Recommended Stories

Before you consider Teradyne, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teradyne wasn't on the list.
While Teradyne currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.